Article
Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies.
Pharmacogenetics - 1 Jun 1997
Schulz W A, Krummeck A, Rösinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Dräger B J, Sies H
Abstract excerpt
The NQO1 locus on chromosome 16q2.2 encodes NAD(P)H:quinone oxidoreductase, an enzyme implicated in detoxication and protection against redox cycling. Two alleles have been identified in the human population, the rarer one, termed the null-allele, coding for a nonfunctional enzyme. Since lack of NQOR activity has been suggested to increase susceptibility to certain cancers, the distribution of the two alleles was...
Topics
- Alleles
- Carcinoma
- Carcinoma, Renal Cell
- Female
- Gene Frequency
- Genotype
- Humans
- Male
- NAD(P)H Dehydrogenase (Quinone)
- Odds Ratio
- Urologic Neoplasms
